Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction
about
Proteomics for rejection diagnosis in renal transplant patients: Where are we now?Applications of urinary proteomics in biomarker discoveryProteomics and metabolomics in renal transplantation-quo vadis?Relative quantitation of neuropeptides over a thousand-fold concentration range.Targeted quantitative phosphoproteomic analysis of erythrocyte membranes during blood bank storage.Proteomic signatures in plasma during early acute renal allograft rejectionLabel-free proteomics reveals decreased expression of CD18 and AKNA in peripheral CD4+ T cells from patients with Vogt-Koyanagi-Harada syndromeLabel-free quantitation of phosphopeptide changes in erythrocyte membranes: towards molecular mechanisms underlying deformability alterations in stored red blood cells.Biomarkers in renal transplantation: An updated review.Shotgun proteomics identifies proteins specific for acute renal transplant rejection.Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.Analysis of the differentially expressed low molecular weight peptides in human serum via an N-terminal isotope labeling technique combining nano-liquid chromatography/matrix-assisted laser desorption/ionization mass spectrometry.Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS.Mechanistic peptidomics: factors that dictate specificity in the formation of endogenous peptides in human milk.Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.Current peptidomics: applications, purification, identification, quantification, and functional analysisDifference gel electrophoresis identifies differentially expressed proteins in endoscopically collected pancreatic fluidInvestigating endogenous peptides and peptidases using peptidomicsProfiling protease activities by dynamic proteomics workflows.Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for kidney allograft rejection.An Optimized Informatics Pipeline for Mass Spectrometry-Based Peptidomics.Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis?Quantitation of endogenous peptides using mass spectrometry based methods.Biological signalling activity measurements using mass spectrometry.Profiling the proteome in renal transplantation.Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS.High-Throughput Proteomic Approaches to the Elucidation of Potential Biomarkers of Chronic Allograft Injury (CAI).Current status and advances in quantitative proteomic mass spectrometry.Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.Biomarkers that predict diabetic nephropathy: the long road from finding targets to clinical use.Urinary peptidomics in kidney disease and drug research.Development of a label-free LC-MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy.A stable panel comprising 18 urinary proteins in the human healthy population.Nucleoid-enriched proteomes in developing plastids and chloroplasts from maize leaves: a new conceptual framework for nucleoid functions.Structural and metabolic transitions of C4 leaf development and differentiation defined by microscopy and quantitative proteomics in maize.
P2860
Q26751478-CFF2B0CB-08E0-42AC-96A5-39E328F7EB9DQ27010368-1CC7D2AF-1E5A-4610-8BA7-D215BBAEB6B9Q27024418-C1907ECD-A88C-46EA-A9A6-398482A7D189Q31095533-34570C18-C39C-4FD7-9BE0-E7A262CDC3DDQ33457255-1EA171E4-F79D-4C7D-AFEE-8B47960C438BQ33587191-DF532BF9-4E52-4285-9F5C-1B714AD9C0A5Q33812988-71B90B19-E192-4DB1-96EE-8BAD8E2B2445Q33828616-1BAB0CCC-3CDB-4B7E-B956-86BFB0AFBFA4Q33842783-388196D1-8556-4368-8F0E-1C7279A36510Q33903986-455ECF15-5766-4516-B387-0CB91C6CB091Q34187912-D7ED16B4-E715-4C83-B5F9-47EEAC16177EQ34420715-2D433B63-40F4-4801-B662-7CE33F337A4CQ34571042-4AA82109-AC7A-4173-91C4-6ACB4E9FC23EQ34634913-D7CDA059-BB47-4230-8BC0-568786DDB754Q35049696-FC974B2A-71A4-4C37-83DC-3E9CE166270EQ35212347-B3FB690B-BB96-4176-8694-6CD83E6F70E6Q36029032-66FEE94E-D934-4DF8-AD8E-6A5016ADF091Q36163374-CC2C2FE8-20F2-4F0F-ACBF-B60E8458D741Q36199807-DE933F72-F417-4C39-A684-DE0075EF3A9FQ36241222-5FE51ADD-0D61-4416-94FC-5494C1EED0A5Q36305003-CBD0A0A6-EBF1-42ED-BFD8-4D2E1F8E45C9Q36500448-7E20B5AC-8819-4506-8713-DA43DFE7CAC6Q37257611-C8F8900C-A050-4F67-80EC-078CC85BD577Q37839120-1D83E488-06F4-4BE5-9C11-17B90839F808Q37869065-CF8E39F9-552F-4B24-A7DB-9E48A2B1CF9BQ38502483-D1983FAF-B245-42FD-813D-39D3BAC60770Q38934802-6FFA8BF5-F1CB-4CAE-854B-DE5E6C2633D1Q39246192-E8E13E7F-BB39-4906-9717-561FAA326196Q39732824-937C4671-972E-4A2C-BAAF-0BEAB7CFCBCBQ41534193-29A87531-669C-48A6-AC6B-6544FB8C9033Q47781932-01EE1435-73CE-4CFC-BA09-B1ACDEB2A07BQ50996571-DEFA8E6A-E508-4AAC-9121-0BB5F24ED06FQ51344954-B1641951-C12D-49F0-870D-9C64A34414D1Q51848166-3197847C-0DD1-4C5B-8459-C86C4941EFB2Q51895579-148B010B-7510-4C36-A1CA-077A607CD23D
P2860
Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Application of label-free quan ...... chronic allograft dysfunction
@en
Application of label-free quan ...... chronic allograft dysfunction.
@nl
type
label
Application of label-free quan ...... chronic allograft dysfunction
@en
Application of label-free quan ...... chronic allograft dysfunction.
@nl
prefLabel
Application of label-free quan ...... chronic allograft dysfunction
@en
Application of label-free quan ...... chronic allograft dysfunction.
@nl
P2093
P2860
P1476
Application of label-free quan ...... chronic allograft dysfunction
@en
P2093
Amandaé Sol-González
Elisenda Bañon-Maneus
Josep M Campistol
Luis F Quintana
Maria P Alcolea
Pedro R Cutillas
P2860
P304
P356
10.1074/MCP.M900059-MCP200
P577
2009-04-07T00:00:00Z